Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients

about

Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients

Item

http://www.wikidata.org/entity/Q58760729

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Belimumab promotes negative se ...... c lupus erythematosus patients

@en

Belimumab promotes negative se ...... c lupus erythematosus patients

@nl

type

Item

label

Belimumab promotes negative se ...... c lupus erythematosus patients

@en

Belimumab promotes negative se ...... c lupus erythematosus patients

@nl

prefLabel

Belimumab promotes negative se ...... c lupus erythematosus patients

@en

Belimumab promotes negative se ...... c lupus erythematosus patients

@nl

P1476

Belimumab promotes negative se ...... c lupus erythematosus patients

@en

P2093

Anne Davidson

http://www.w3.org/2001/XMLSchema#string

Cosmin Dascalu

http://www.w3.org/2001/XMLSchema#string

Cynthia Aranow

http://www.w3.org/2001/XMLSchema#string

Jian Han

http://www.w3.org/2001/XMLSchema#string

Martin Lesser

http://www.w3.org/2001/XMLSchema#string

Meggan Mackay

http://www.w3.org/2001/XMLSchema#string

Miranda Byrne-Steele

http://www.w3.org/2001/XMLSchema#string

Qunying Yang

http://www.w3.org/2001/XMLSchema#string

Richard Furie

http://www.w3.org/2001/XMLSchema#string

Tam D Quach

http://www.w3.org/2001/XMLSchema#string

P2860

The analysis of clonal expansions in normal and autoimmune B cell repertoires

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Predominant autoantibody production by early human B cell precursors

Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus

Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.

Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF

Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus.

ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells.

P31

scholarly article

P356

10.1172/JCI.INSIGHT.122525

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30185675

http://www.w3.org/2001/XMLSchema#string

P932

6171800

http://www.w3.org/2001/XMLSchema#string